Health Blogs (951)

A friend of mine came back from his chiropractor and he informed my friend that this virus is interesting. My friend told me, he was not sure using the word mutate was correct...but he explained it this way to me. He said, according to his doctor, if he got the virus and gave it to me, I would have a different virus than him.

I have just heard tonight on tv....not only can you get the virus more than once, but the second time around it is more vicious than the first time. That would make sense if my friend was told correct by his chiropractor.

It sounds like this virus is like a moving target...if everything I had been told is correct.

It sounds like a vaccine is essential with this....otherwise, is there a way of stopping it without everyone being effected by it?




...sounds serious....and something to be treated as such...

be safe all

Hopefully I have heard wrong...and drew the wrong conclusions.

Seriously people, there is an end for women to produce trophy babies for some old fart! Its called "geriatric pregnancy". If you start a pregnancy for a woman at 60 please do the math. I find it a bit ridiculous.
The question on the profile is Want kids? most of answers are" not sure", really at 60 years you don't know if you want kids? what planet have you guys been visiting? Just because technology allows people to play God, is this a mentally health issue? ego? .

....Highly specialized staff and technology, where the most compromised of Covid-19 patients stay, often for weeks. Similar units for trauma, post surgery, cardiac stepdown and in some ways for psychiatry. Considerable mortality among such staff working with these sickest of patients. Today, a young doctor talked on radio about staff experience over the past months. While always an intense and demanding practice environment, all supporting each other as a team, allowing some respite for individuals, even if only for a few minutes to eat, to rest and possibly to call home. Highly skilled nurses, pulmonary and Xray technicians, and many more make it happen. Monitors for nearly every vital bodily, and even brain function, and life support pumps/medication delivery pumps, etc. do contribute. Nearly instant laboratory results. Yet, we hear that things are more demanding these days. And that's for places with enough equipment, staff and no overload of patients. Burn out is always a risk in demanding work places. Normally, the importance of the jobs, and neediness of their charges, keep morale high. But it seems even these folks have their limits. This young physician seems close to reaching his. And many are getting sick---and worse. Many Europeans are out on their balconies applauding these medical heroes. Why not?

It came out on 3/31/2020 which is today's date.

That's a quote.. it wasn't me doing the shouting.
I've been listening to a few videos by Doctor Vong and this guy talks about the reality of coronavirus. The death rate will increase. Hospitals are at capacity, medical staff are working without proper protective equipment and are falling to the virus. Doctors are dying.
He states percentages of risk factors for people who are obese, have hypertension, are diabetic and have respiratory disease. Those on ventilators have an average stay of 2 weeks. He gives details how the virus attacks the lungs and his explanations (with diagrams) are very clear and easy to understand.
Worth a listen.

I saw this last night 3/30/2020

Race to find COVID-19 treatments accelerates
In Section: IN DEPTH
WHO launches megatrial to test repurposed drugs and experimental drug candidates
By Kai Kupferschmidt and Jon Cohen

INFECTIOUS DISEASES

With cases of the new coronavirus disease 2019 (COVID-19) climbing steeply everywhere from Madrid to Manhattan , overwhelming one hospital after another and pushing the global death toll past 17,000, the sprint to find treatments has dramatically accelerated. Drugs that stop the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), could save the lives of severely ill patients, protect health care workers and others at high risk of infection, and reduce the time patients spend in hospital beds.

The World Health Organization (WHO) last week announced a major study to compare treatment strategies in a streamlined clinical trial design that doctors around the world can join. Other trials are also underway; all told, at least 12 potential COVID-19 treatments are being tested, including drugs already in use for HIV and malaria, experimental compounds that work against an array of viruses in animal experiments, and antibody-rich plasma from people who have recovered from COVID-19. More than one strategy may prove its worth, and effective treatments may work at different stages of infection, says Thomas Gallagher, a coronavirus researcher at Loyola University Chicago’s Health Sciences Campus. “The big challenge may be at the clinical end determining when to use the drugs.”

Researchers want to avoid repeating the mistakes of the 2014–16 West African Ebola epidemic, in which willy-nilly experiments proliferated but randomized clinical trials were set up so late that many ended up not recruiting enough patients. “The lesson is you start trials now,” says Arthur Caplan, a bioethicist at New York University’s Langone Medical Center. “Make it a part of what you’re doing so that you can move rapidly to have the most efficacious interventions come to the front.”

To that end, WHO on 20 March announced the launch of SOLIDARITY, an unprecedented, coordinated push to collect robust scientific data rapidly during a pandemic. The study, which could include many thousands of patients in dozens of countries, has emphasized simplicity so that even hospitals overwhelmed by an onslaught of COVID-19 patients can participate. WHO’s website will randomize patients to local standard care or one of the four drug regimens, using only ones available at the patient’s hospital. Physicians will simply record the day the patient left the hospital or died, the duration of the hospital stay, and whether the patient required oxygen or ventilation. “That’s all,” says Ana Maria Henao Restrepo, a medical officer at WHO’s Department of Immunization Vaccines and Biologicals.

The design is not blinded: Patients will know they received a drug candidate, and that could cause a placebo effect, Henao Restrepo concedes. But it is in the interest of speed, she says. “We are doing this in record time.” The agency hopes to start to enroll patients this week.

Rather than taking years to develop and test compounds from scratch, WHO and others want to repurpose drugs that are already approved for other diseases and have acceptable safety profiles. They’re also looking at experimental drugs that have performed well in animal studies against the other two deadly coronaviruses, which cause SARS and Middle East respiratory syndrome (MERS). And they are focusing on compounds plentiful enough to treat a substantial number of patients.

COULD ONLY LOAD HALF THE ARTICLE - WRITE ME IF YOU WANT MORE

As I sat down on my couch tired and exhausted I still felt like I am not still home but just thanked God I am home and safe feeling not alright thinking of those
patients suffering from symptoms and hoping and praying tests will be negative of this COVID - 19
Iloveu all keep safe

... In volume one of the memoirs, your intrepid Institute Director, explores classification of behavioral syndromes. Specifically, how, while the accepted features of childhood s*xual trauma induced chronic adult PTSD have heuristic value, as most therapists well know, they just scratch the surface of important human challenges, and of therapeutic recoveries from such. In every day life, subtle issues of perception, judgement, interpersonal messaging, and much more, are at least as important as nightmares/re-experiencing/avoidance, and the lot. In doing so, he began thinking of things political. Gotta walk Bravo, later, alligators.